Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Senti Biosciences Holdings, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q1 2026
- Shares held
- 5.79M
- +154.2K (+2.7%) vs. Q1 2026
- Total value
- $6.37M
- +$1.79M (+39.2%) vs. Q1 2026
- New holders
- 6
- 4 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 169 | $186 | 0.00% | +9+5.6% | Added |
| SBI Securities Co., Ltd. | 334 | $367 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 768 | $845 | 0.00% | +768 | New |
| Royal Bank of Canada | 4,015 | $4.00K | 0.00% | +4,015 | New |
| BlackRock, Inc. | 4,004 | $4.40K | 0.00% | −21,070−84.0% | Reduced |
| Tower Research Capital LLC (TRC) | 7,344 | $8.08K | 0.00% | +7,344 | New |
| State Street Corp | 10,010 | $11.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14,432 | $15.9K | 0.00% | +5,795+67.1% | Added |
| Virtu Financial LLC | 22,795 | $25.0K | 0.00% | +22,795 | New |
| XTX Topco Ltd | 23,610 | $26.0K | 0.00% | +6,333+36.7% | Added |
| Northern Trust Corp | 32,154 | $35.4K | 0.00% | +15,376+91.6% | Added |
| Menlo Ventures Management, L.P. | 35,737 | $39.3K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 52,530 | $57.8K | 0.00% | +52,530 | New |
| Vanguard Fiduciary Trust Co | 91,193 | $100.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 107,100 | $117.8K | 0.00% | +107,100 | New |
| Geode Capital Management, LLC | 187,065 | $205.8K | 0.00% | −19,978−9.6% | Reduced |
| Vanguard Capital Management LLC | 537,504 | $591.3K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 888,000 | $976.8K | 0.06% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,775,615 | $4.15M | 0.26% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −14,844−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |